论文部分内容阅读
美国每年有10,000人死于膀胱癌,几乎均死于肿瘤的肌层浸润或转移。作者对101例膀胱癌患者行根治性膀胱切除术,手术适应症为:侵及肌层的膀胱癌(T_2,T_3,T_4),侵及前列腺导管的原位癌(CIS),TUR加腔内化疗后复发或持续存在的高分级肿瘤。该组患者中男74例,女27例;移行细胞癌(TCC)占80％,鳞状细胞癌(SCC)占14％,腺癌占 3％。通常鳞癌约占膀胱肿瘤的3～5％,而该组女性患者中鳞癌高达30％,男性为6％,两者比例为5:1。鳞癌是恶性度更高的肿瘤,多为侵润癌,5年生存率仅16～20％,该组女性鳞癌患
Every year in the United States 10,000 people die of bladder cancer, almost all of which die from tumor invasion or metastasis. The authors performed radical cystectomy on 101 patients with bladder cancer. The surgical indications were bladder cancer (T 2, T 3, T 4), invasion of prostate duct (CIS), TUR plus lumen Chemotherapy after recurrence or persistent high-grade tumors. The group of 74 patients with males and 27 females; transitional cell carcinoma (TCC) accounted for 80%, 14% of squamous cell carcinoma (SCC), adenocarcinoma accounted for 3%. Squamous carcinoma usually accounts for about 3 to 5% of the bladder tumor, while squamous cell carcinoma in this group of women is as high as 30%, 6% of men, the ratio of the two is 5: 1. Squamous cell carcinoma is a more malignant tumor, mostly invasive carcinoma, 5-year survival rate of only 16 to 20%, the group of female squamous cell carcinoma